This matters for salaried professionals, startup employees, executives, and NRIs who receive ESOPs as part of their compensation. Get the timing wrong and you're looking at unexpected tax bills, TDS shortfalls, or a scrutiny notice from the tax department.
Here's the misconception that trips up most people: they assume ESOP tax only applies when they sell. In reality, the first (and often larger) liability arises at exercise, before you've seen a single rupee in cash. This article breaks down both the perquisite tax and capital gains tax on ESOPs, walks through the calculations with real numbers, and covers startup deferral rules and NRI-specific factors.
Key Takeaways
- ESOPs face tax twice: as a perquisite at exercise, and as capital gains at sale
- Perquisite tax = (FMV − exercise price) × shares, taxed at your income slab rate
- Capital gains at sale = sale price − FMV on exercise date (not exercise price)
- Eligible startup employees can defer perquisite tax payment for up to 48 months
- Grant and vesting trigger zero tax — only exercise and sale do
What Is ESOP Taxation & Why It's Structured in Two Stages
An Employee Stock Option Plan (ESOP) lets you buy company shares at a fixed, often discounted price after a vesting period. The catch: Indian tax law doesn't tax you the moment you're granted this right. It waits for two specific milestones.
The ESOP lifecycle runs through four stages:
- Grant date — the company offers you the option (no tax)
- Vesting period — you earn the right to exercise (no tax)
- Exercise date — you actually buy the shares (perquisite tax triggers)
- Sale — you sell the shares (capital gains tax triggers)
The taxable "benefit" only crystallises once you exercise. Under Section 17(2)(vi) of the Income-tax Act, securities allotted free of cost or at a concessional rate count as a perquisite in the year of exercise. Anything you gain afterward, when you eventually sell, falls under Capital Gains instead.
ESOPs vs RSUs: A Quick Distinction
People often lump these together, but they work differently for tax purposes:
| Aspect | RSUs | ESOPs |
|---|---|---|
| Purchase price | None required | Exercise price required |
| Taxable event | Full value taxed at vesting | Only the "spread" — fair market value (FMV) minus exercise price — taxed at exercise |
This two-stage structure exists for a reason. It separates your "employment benefit" (the perquisite, taxed as salary) from your "investment gain" (the capital appreciation you earn once you become an actual shareholder).
How ESOP Tax Is Calculated: Step-by-Step
Your total ESOP tax bill combines two separate calculations: a one-time perquisite tax at exercise, and a capital gains tax whenever you eventually sell. Both get tracked and filed independently.
Step 1: Grant & Vesting — No Tax Trigger
Nothing happens here from a tax standpoint. Grant and vesting simply mark the period during which you earn the right to buy shares, typically spread across three to four years with a one-year cliff before the first tranche vests. Since no money changes hands and no shares transfer yet, there's nothing to report on your tax return at this stage. Many employees assume tax applies the moment shares vest, but the real trigger arrives at Step 2: exercise.
Step 2: Exercise — Perquisite Tax
This is where your first tax bill appears. The formula is straightforward:
Perquisite value = (FMV on exercise date − exercise price paid) × number of shares
Your employer adds this value directly to your salary income and taxes it at your applicable slab rate. The FMV calculation method depends on whether your company is listed:
- Listed shares: Average of the opening and closing price on the exercise date. If there's no trading that day, the closing price from the closest preceding trading day applies
- Unlisted shares: A SEBI-registered merchant banker determines the value, dated the exercise date or up to 180 days prior, per Rule 3 of the Income-tax Rules
Worked example:
| Detail | Value |
|---|---|
| Exercise price | ₹50/share |
| FMV on exercise date | ₹350/share |
| Number of shares | 1,000 |
| Perquisite value | (₹350 − ₹50) × 1,000 = ₹3,00,000 |
| Tax at 30% slab | ₹90,000 (plus applicable cess) |
Your employer must deduct this as TDS under Section 192, adding it to your regular monthly salary TDS calculation.
Step 3: Sale — Capital Gains Tax
When you eventually sell, the formula changes:
Capital gain = Sale price − FMV on exercise date
Notice this uses FMV on exercise, not your original exercise price. Your perquisite calculation already accounted for the exercise price, so it doesn't get deducted twice. The holding period counts from the date of allotment, not the grant or vesting date.
Current rates for transfers on or after 23 July 2024:
| Category | Short-term | Long-term |
|---|---|---|
| Listed shares (STT paid) | 20% if held ≤12 months | 12.5% if held >12 months, on gains above ₹1.25 lakh exemption |
| Unlisted shares | Slab rate if held ≤24 months | 12.5% without indexation, if held >24 months |
Source: CBDT's FAQ on the new capital gains regime
Worked example (continuing from above): Say you sell those 1,000 shares 18 months after allotment at ₹500 each.
- Sale price: ₹500 × 1,000 = ₹5,00,000
- FMV at exercise: ₹350 × 1,000 = ₹3,50,000
- Capital gain: ₹1,50,000
- Since held over 12 months and listed with STT paid, this qualifies as LTCG
- Taxable gain after ₹1.25 lakh exemption: ₹25,000
- Tax at 12.5%: ₹3,125
Key Factors That Affect Your ESOP Tax Liability
A handful of variables can dramatically change what you actually owe, and when. Here's what to watch for.
Startup deferral relief: Under Section 192(1C), employees of eligible startups (recognised under Section 80-IAC) can defer their perquisite TDS payment. The employer deducts or pays this tax within 14 days of the earliest of:
- The date 48 months after the end of the assessment year of allotment
- The date you sell the shares
- The date you leave the company
Eligibility requires the company to be incorporated between 1 April 2016 and 1 April 2030, hold turnover under ₹100 crore, and carry a valid Inter-Ministerial Board certificate under Section 80-IAC.
NRI and cross-border scenarios: If you're granted ESOPs while resident but exercise them as an NRI (or the reverse), your taxability shifts. Relief may be available under a Double Taxation Avoidance Agreement, but you'll need a valid Tax Residency Certificate to claim it.
Listing status matters twice over: Whether your company is listed changes both your FMV method and your capital gains rate/holding threshold. A startup employee and a listed-company executive can face very different outcomes on identical rupee gains.
Advance tax obligations: If employer TDS doesn't cover your full liability, especially capital gains on sale, you're on the hook for advance tax. Miss it, and interest under Sections 234B and 234C kicks in.
Repatriation for NRIs: Whether you can move your ESOP sale proceeds abroad depends on your residential status at exercise and which account you used. NRE funds are fully repatriable; NRO funds face a cumulative annual cap.
Between startup deferral, cross-border rules, DTAA claims, and advance tax timing, these factors overlap in ways that are easy to miss.
Cambridge Wealth works with professionals and NRIs on how ESOP proceeds sit alongside the rest of their portfolio — what the money is earmarked for, the timeline attached to that goal, and the liquidity needed along the way. That context turns a decision that looks simple on paper into one made with the full picture visible.
Common Issues, Misconceptions & Timing Considerations
Even employees who've read the rules once still stumble on the same handful of points. Here's what trips people up most.
"ESOP tax only applies when I sell." This is the single biggest misconception. Perquisite tax at exercise is mandatory, and it's a real cash outflow before you've sold a single share or seen any liquidity.
Confusing FMV at grant with FMV at exercise. Only the FMV on your exercise date matters. It determines your perquisite value, and it becomes your cost basis for future capital gains calculations. FMV at grant is irrelevant for tax purposes.
Exercising immediately isn't always smart. Before you exercise, weigh:
- Proximity of any expected liquidity event
- Illiquidity risk if your company's shares remain unlisted
- Upcoming expiry dates on your options
- Availability of cash to cover the perquisite tax bill
Documentation gaps cause problems later. Hold onto your grant letter, allotment letter, and any FMV valuation reports. These documents matter for accurate ITR disclosure, and they're your first line of defence if the tax department raises questions later.
Frequently Asked Questions
How are ESOPs taxed in India?
ESOPs face tax at two points: a perquisite tax at exercise (added to salary, taxed at your slab rate), and a capital gains tax at sale (based on holding period and listing status).
Do I need to declare ESOP in ITR?
Yes. Both the perquisite value (in the year of exercise) and capital gains (in the year of sale) must be disclosed. Startup deferral only postpones the payment, not the disclosure obligation.
What is the ESOP 25% rule?
There's no formal statutory "25% rule" in Indian tax law. This usually refers to a common vesting schedule convention in ESOP plan documents, not a tax provision. Always check your specific scheme document.
How is the Fair Market Value (FMV) of unlisted ESOP shares determined?
FMV for unlisted shares is determined by a SEBI-registered merchant banker, valued as on the exercise date or up to 180 days prior, per Rule 3 of the Income-tax Rules.
Can NRIs repatriate proceeds from selling ESOP shares in India?
Yes, but it depends on your residential status at exercise and the account type used. NRE account proceeds are fully repatriable; NRO account proceeds are capped at USD 1 million per financial year under the RBI's Liberalised Remittance Scheme, subject to Form 15CA/15CB certification.
What tax benefit is available for ESOPs from eligible start-ups?
Under Section 80-IAC, eligible startup employees can defer their perquisite tax payment to the earliest of 48 months from allotment, leaving the company, or selling the shares.
